Blockade of XBP1 splicing by inhibition of IRE1 is a promising therapeutic option in multiple myeloma
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blockade of XBP1 splicing by inhibition of IRE1 is a promising therapeutic option in multiple myeloma
Authors
Keywords
-
Journal
BLOOD
Volume 119, Issue 24, Pages 5772-5781
Publisher
American Society of Hematology
Online
2012-04-27
DOI
10.1182/blood-2011-07-366633
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potent and Selective Inhibitors of the Inositol-requiring Enzyme 1 Endoribonuclease
- (2011) Kori Volkmann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma
- (2011) S K Martin et al. LEUKEMIA
- Multiple Myeloma
- (2011) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiple Myeloma
- (2010) Jacob Laubach et al. Annual Review of Medicine
- PI3K/p110 is a novel therapeutic target in multiple myeloma
- (2010) H. Ikeda et al. BLOOD
- XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments
- (2010) T. Bagratuni et al. BLOOD
- Identification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma
- (2010) I. Papandreou et al. BLOOD
- Low bone marrow oxygen tension and hypoxia-inducible factor-1α overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138+ cells
- (2010) S Colla et al. LEUKEMIA
- Dual Inhibition of Akt/Mammalian Target of Rapamycin Pathway byNanoparticle Albumin-Bound–Rapamycin and Perifosine Induces Antitumor Activity in Multiple Myeloma
- (2010) Diana Cirstea et al. MOLECULAR CANCER THERAPEUTICS
- Biologic sequelae of I B kinase (IKK) inhibition in multiple myeloma: therapeutic implications
- (2009) T. Hideshima et al. BLOOD
- The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells In vitro and In vivo
- (2009) H. Ikeda et al. CLINICAL CANCER RESEARCH
- XBP-1 regulates signal transduction, transcription factors and bone marrow colonization in B cells
- (2009) Chih-Chi Andrew Hu et al. EMBO JOURNAL
- Bone marrow microenvironment and the identification of new targets for myeloma therapy
- (2008) K Podar et al. LEUKEMIA
- ERdj4 and ERdj5 Are Required for Endoplasmic Reticulum-associated Protein Degradation of Misfolded Surfactant Protein C
- (2008) Mei Dong et al. MOLECULAR BIOLOGY OF THE CELL
- Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities
- (2008) Inki Kim et al. NATURE REVIEWS DRUG DISCOVERY
- Regulation of Hepatic Lipogenesis by the Transcription Factor XBP1
- (2008) A.-H. Lee et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now